Scientists have introduced a second molecule to achieve a donor–acceptor (push–pull) effect, aiming to enhance both the ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...